Advertisement
Atherosclerosis
Advanced SearchSave search
Research paper| Volume 75, ISSUE 1, P31-38, January 01, 1989

Formation of 15-hydroxyeicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe Heritable Hyperlipidemic and cholesterol-fed rabbits

DOI:https://doi.org/10.1016/0021-9150(89)90204-9
Formation of 15-hydroxyeicosatetraenoic acid (15-HETE) as the predominant eicosanoid in aortas from Watanabe Heritable Hyperlipidemic and cholesterol-fed rabbits
Previous ArticleSpontaneous injuries in the aortic endothelium of the inherited cataract rats and their prevention by tocopherol A study by scanning electron microscopy
Next ArticleMarine lipid concentrate and atherosclerosis in the rabbit model
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Atherosclerotic plaque formation is accompanied by hyperproliferative events which have many features of an inflammatory response. A high-performance liquid chromatography procedure was developed to analyze the inflammatory prostaglandins, leukotrienes and hydroxyeicosatetraenoic acids (HETEs) produced by aortic segments. Normal rabbit aortas incubated with tritiated arachidonic acid synthesized 12-HETE as the principal lipoxygenase metabolite, and prostacyclin as the major cyclooxygenase product. In contrast, atherosclerotic aortas from both cholesterol-fed and Watanabe Heritable Hyperlipidemic rabbits showed major increases in synthesis of lipoxygenase-derived 15-HETE, which became the predominant eicosanoid in the aortas of both types of rabbit. No leukotrienes or other 5-lipoxygenase products were detected to the detection limit of 0.5 pmol/cm aorta. 15-HETE, which is chemotactic for smooth muscle cells, mitogenic for endothelial cells, and an inhibitor of prostacyclin synthesis may thus play a role in atherogenesis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Needleman P.
        • Turk J.
        • Jakschik B.A.
        • Morrison A.R.
        • Lefkowith J.B.
        Arachidonic acid metabolism.
        Ann. Rev. Biochem. 1986; 55: 69
        • Simmet T.
        • Peskar B.A.
        Eicosanoids and the coronary circulation.
        Rev. Biochem. Pharm. 1986; 104: 1
        • Willis A.L.
        • Smith D.L.
        • Vigo C.
        Suppression of principal atherosclerotic mechanisms by prostacyclins and other eicosanoids.
        Prog. Lipid Res. 1986; 25: 645
        • Davies P.
        • Bailey P.J.
        • Goldenberg M.M.
        • Ford-Hutchinson A.W.
        The role of arachidonic acid oxygenation in pain and inflammation.
        Ann. Rev. Immunol. 1984; 2: 335
        • Lopes-Virella M.F.
        • Virella G.
        Immunological and microbiological factors in the pathogenesis of atherosclerosis.
        Clin. Immunol. Immunopath. 1985; 37: 377
        • Schwartz C.J.
        • Valente A.J.
        • Sprague E.A.
        • Kelley J.L.
        • Suenram C.A.
        • Graves D.T.
        • Rozek M.M.
        • Edwards E.H.
        • Delgado R.
        Monocyte-macrophage participation in atherogenesis: inflammatory components of pathogenesis.
        Sem. Thromb. Hemostasis. 1986; 12: 79
        • Heam J.A.
        The pathogenesis of atherosclerosis.
        Lancet. 1986; 315: 643
        • Hirosumi J.
        • Nomoto A.
        • Ohkubo Y.
        • Sekiguchi C.
        • Seitaro M.
        • Yamaguchi I.
        • Aoki H.
        Inflammatory responses in cuff-induced atherosclerosis in rabbits.
        Atherosclerosis. 1987; 64: 243
        • Bailey J.M.
        • Butler J.
        Anti-inflammatory drugs in experimental atherosclerosis, Part 1 (Relative potencies for inhibiting plaque formation).
        Atherosclerosis. 1973; 17: 515
        • Mathur S.N.
        • Field F.J.
        • Spector A.A.
        • Armstrong M.L.
        Increased production of lipoxygenase products by cholesterol-rich mouse macrophages.
        Biochim. Biophys. Acta. 1985; 837: 13
        • Mathur S.N.
        • Field F.J.
        Effect of cholesterol enrichment on 12-hydroxyeicosatetraenoic acid metabolism by mouse peritoneal macrophages.
        J. Lipid Res. 1987; 28: 1166
        • Nakao J.
        • Ooyama T.
        • Chang W.
        • Murota S.
        • Orimo H.
        Platelets stimulate aortic smooth muscle cell migration in vitro.
        Atherosclerosis. 1982; 43: 143
        • Nakao J.
        • Ooyama T.
        • Ito H.
        • Chang W.
        • Murota S.
        Comparative effect of lipoxygenase products of arachidonic acid on rat aortic smooth muscle cell migration.
        Atherosclerosis. 1982; 44: 339
        • Shimokawa H.
        • Tomoike H.
        • Nabeyama S.
        • Yamamoto H.
        • Araki H.
        • Nakamura M.
        • Ishii Y.
        • Tanaka K.
        Coronary artery spasm induced in atherosclerotic miniature swine.
        Science. 1983; 221: 560
        • Lee T.H.
        • Austen K.F.
        • Corey E.J.
        • Drazen J.M.
        Leukotriene E4 4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle cell to histamine and evidence for three separate sulfidopeptide leukotriene receptors.
        in: 7th edn. Proc. Natl. Acad. Sci. USA. 81. 1984: 4922
        • Wittman G.
        • Peskar B.M.
        • Edelmann M.
        • Muller K.M.
        • Simmet T.
        • Peskar B.A.
        Formation of cysteinyl-containing leukotrienes by human arterial tissues.
        Prostaglandins. 1987; 33: 591
        • Forman M.B.
        • Oates J.A.
        • Robertson D.
        • Robertson R.M.
        • Roberts L.J.
        • Virmani R.
        Increased adventitial mast cells in a patient with coronary spasm.
        New Engl. J. Med. 1985; 313: 1138
        • Hartung H.
        • Kladetzky R.G.
        • Melnik B.
        • Hennerici M.
        Stimulation of the scavenger receptor on monocytesmacrophages evokes release of arachidonic acid metabolites and reduced oxygen species.
        Lab. Invest. 1986; 55: 209
        • Schwartz C.J.
        • Sprague E.A.
        • Kelley J.L.
        • Valente A.J.
        • Suenram C.A.
        Aortic intimal monocyte recruitment in the normo- and hypercholesterolemic baboon (Papio cynocephalus).
        Virchow's Arch. 1985; 405: 175
        • Henriksson P.
        • Hamberg M.
        • Diczfalusy U.
        Formation of 15-HETE as a major hydroxyeicosatetraenoic acid in the atherosclerotic vessel wall.
        Biochim. Biophys. Acta. 1985; 834: 272
        • Powell W.S.
        Formation of 6-oxoprostaglandin F1α, 6,15dioxoprostaglandin f1α and monohydroxyeicosatetraenoic acids from arachidonic acid by fetal calf aorta and ductus arteriosus.
        J. Biol. Chem. 1982; 257: 9457
        • Setty B.N.Y.
        • Stuart M.J.
        • Walenga R.W.
        Formation of 11-hydroxyeicosatetraenoic acid and 15-hydroxyeicosatetraenoic acid in human umbilical arteries is catalyzed by cyclooxygenase.
        Biochim. Biophys. Acta. 1985; 833: 484
        • Bailey J.M.
        • Bryant R.W.
        • Whiting J.
        • Salata K.
        Characterization of 11-HETE and 15-HETE, together with prostacyclin, as major products of the cyclooxygenase pathway in cultured rat aorta smooth muscle cells.
        J. Lipid Res. 1983; 24: 1419
        • Gryglewski R.J.
        • Dembińska-Kièć A.
        • Z̊muda A.
        • Gryglewski T.
        Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries, and platelets at various stages of experimental atherosclerosis in rabbits.
        Atherosclerosis. 1978; 31: 385
        • Porter N.A.
        • Logan J.
        • Kontoyiannidou V.
        Preparation and purification of arachidonic acid hydroperoxides of biological importance.
        J. Org. Chem. 1979; 44: 3177
        • Bailey J.M.
        • Butler J.
        Anti-inflammatory drugs in experimental atherosclerosis, Part 5 (Influence of cortisone acetate on short-term and long-term cholesterol fluxes in atherosclerotic aorta).
        Atherosclerosis. 1984; 51: 299
        • Tanzawa K.
        • Shimada Y.
        • Kuroda M.
        • Tsujita Y.
        • Arai M.
        • Watanabe Y.
        WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia.
        FEBS Lett. 1980; 118: 81
        • Eskra J.D.
        • Pereira M.J.
        • Ernst M.J.
        Solid phase extraction and high-performance liquid chromatography analysis of lipoxygenase pathway products.
        Anal. Biochem. 1986; 154: 332
      29. 7th edn. Lipid Research Clinics Program, Manual of Laboratory Operations, Vol. I (Lipid and Lipoprotein Analysis) (DHEW Publication, No. (NIH) 75–628). National Institutes of Health, Bethesda, MD1974
        • McGill H.C.
        • Eggen D.A.
        • Strong J.P.
        Atherosclerotic lesions in the aorta and coronary arteries of man.
        in: Roberts J.C. Straus R. Comparative Atherosclerosis. Harper and Row, New York1965: 311
        • Setty B.N.Y.
        • Graeber J.E.
        • Stuart M.J.
        The mitogenic effect of 15- and 12-hydroxyeicosatetraenoic acid on endothelial cells may be mediated via diacylglycerol kinase inhibition.
        J. Biol. Chem. 1987; 262: 17613
        • Moncada S.
        • Gryglewski R.J.
        • Bunting S.
        • Vane J.
        A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation.
        Prostaglandins. 1976; 12: 715
        • Setty B.N.Y.
        • Stuart M.J.
        15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in human diabetic vascular disease.
        J. Clin. Invest. 1986; 77: 202
        • Coene M.
        • Bult H.
        • Claeys M.
        • Laekeman G.M.
        • Herman A.G.
        Inhibition of rabbit platelet activation by lipoxygenase products of arachidonic and linoleic acid.
        Thrombosis Res. 1986; 42: 205
        • Thomas G.
        • Ramwell P.
        Induction of vascular relaxation by hydroperoxides.
        Biochem. Biophys. Res. Common. 1986; 139: 102
        • Takahashi M.
        • Ozaki N.
        • Kawakita S.
        • Nozaki M.
        • Saeki Y.
        Vascular effects of 15-hydroperoxyeicosatetraenoic acid and 15-hydroxyeicosatetraenoic acid on canine arteries.
        Jap. J. Pharm. 1985; 37: 325
        • D'Alarao M.
        • Corey E.J.
        • Cunard D.
        • Ramwell P.
        • Uotila P.
        • Vargas R.
        • Wroblewska B.
        The vasodilation induced by hydroperoxy metabolites of arachidonic acid in the rat mesenteric and pulmonary circulation.
        Br. J. Pharmacol. 1987; 91: 627
        • Saito H.
        • Salmon J.A.
        • Moncada S.
        Influence of cholesterol feeding on the production of eicosanoids, tissue plasminogen activator and superoxide anion (O2−) by rabbit blood monocytes.
        Atherosclerosis. 1986; 61: 141
        • Turk J.
        • Maas R.L.
        • Brash A.R.
        • Roberts L.J.
        • Oates J.A.
        Arachidonic acid 15-lipoxygenase products from human eosinophils.
        J. Biol. Chem. 1982; 257: 7068
        • Nakao J.
        • Koshihara Y.
        • Ito H.
        • Murota S.
        • Chang W.
        Enhancement of endogenous production of 12l-hy-droxy-5,8,11,13-eicosatetraenoic acid in aortic smooth muscle cells by platelet-derived growth factor.
        Life Sci. 1985; 37: 1435
        • Hopkins N.K.
        • Oglesby T.D.
        • Bundy G.L.
        • Gorman R.R.
        Biosynthesis and metabolism of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid by human umbilical vein endothelial cells.
        J. Biol. Chem. 1984; 259: 14048

      Article Info

      Publication History

      Accepted: August 8, 1988
      Received in revised form: August 3, 1988
      Received: February 15, 1988

      Identification

      DOI: https://doi.org/10.1016/0021-9150(89)90204-9

      Copyright

      © 1989 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX